European Commission logo
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-23

Praziquantel: its central role in the chemotherapy of schistosome infection

Objective

This proposal will be centred on aspects of praziquantel usage and will involve a group of scientists from disease endemic countries (with a major focus on Africa). They will be linked with a group of scientists from European Member States who share their common interest in researching the clinical, biological, epidemiological , pharmacological and socio-economic aspects of praziquantel use for the control of schistosome infection and disease. The Concerted Action will provide rational answers to questions related to the use of praziquantel in order to arm national health authorities and international agencies with appropriate information to ensure implementation of effective control programmes using praziquantel . The project will provide methodological tools to deal with any outbreak of drug resistant parasites and will develop strategies that if implemented will reduce the likelihood of emergence of drug resistant parasites

Programme(s)

Topic(s)

Data not available

Call for proposal

Data not available

Funding Scheme

CON - Coordination of research actions

Coordinator

UNIVERSITY OF GLASGOW
EU contribution
No data
Address
University Avenue, Joseph Black Building
G12 8QQ GLASGOW
United Kingdom

See on map
Total cost
No data

Participants (20)

Share this page

Download

Last update: 12 April 2005

My Booklet

Permalink: https://cordis.europa.eu/project/id/ICA4-CT-2002-10054

European Union, 2024